Approvals/CIMA-AEMPS/FUROATO DE FLUTICASONA CIPLA 27,5 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL

Approved

STANDARD

FUROATO DE FLUTICASONA CIPLA 27,5 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL

Cipla Europe🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: f9d0e46363c62fc5
Drug Cima Aemps Name: FUROATO DE FLUTICASONA CIPLA 27,5 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL
Register Number: 89998
Holder Company Name: Cipla Europe
Marketing Company Name: Cipla Europe
Authorization Date: 2024-12-11
Dosage Form: SUSPENSIÓN PARA PULVERIZACIÓN NASAL
Dose: 27,5 microgramos/pulverización
Route Of Administration: VÍA NASAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Cipla Europe

FLUTICASONA FUROATO

27,5 µg/pulsación

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Dec 11, 2024

Approval ID

f9d0e46363c62fc5

Type

Standard